Telix Pharmaceuticals | TLX - Costo Del Venduto

Prezzo Delle Azioni
12.75
Cambio Giornaliero
0.34 2.74%
Mensile
32.67%
Annuale
-54.43%
Q1 Previsione
11.05




Costo Del Venduto Cambiamento Data
Cochlear AUD 319.2M 160.35M 2025-12
CSL USD 3.87B 2.08B 2025-12
Integral Diagnostics AUD 11.53M 146K 2024-06
Mayne Pharma AUD 43.74M 2.67M 2024-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Mesoblast USD -7.6M 27.47M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Pacific Edge NZD 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Polynovo AUD 9.02M 3.51M 2025-12
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 536.28M 21.52M 2025-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12